MEDLY PHARMACY: Expands Digital Pharmacy Services Into Baltimore
Medly Continues Nationwide Expansion With the Launch of Digital Pharmacy Services, Including Free, Same-Day Delivery, Into the Baltimore Market Read More »
APHA: Transparency, Safety and Availability Must Be Core Principles for Strengthening America's Drug Supply Chain
The reliability, quality and safety of our nation's drug supply chain are essential to the nation's security and health and well-being of the American public. Read More »
PHARMACY QUALITY SOLUTIONS: Announces Appointment of John Michael O’Brien to Board of Directors
PQS adds former Senior Advisor to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services to its Board of Directors Read More »
HUMANA: Ranks #1 for Customer Satisfaction for Mail Order in J.D. Power Pharmacy Study for Third Year in a Row
Humana Pharmacy, a division of Humana Inc. (NYSE: HUM), has been named the best in Mail Order Pharmacy customer satisfaction in the J.D. Power 2020 U.S. Pharmacy Study. It’s the third consecutive year that Humana has received the prestigious honor. Read More »
John Hopkins study seeks solution for cardiovascular complications of people living with HIV
A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »
AEI expert calls for coordinated world effort to distribute COVID-19 vaccine
James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »
Biopharmaceutical industry reports over 400 medicines, vaccines in development
A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »
AGENUS: Receives $35M In Immuno-Oncology Transaction with Betta Pharmaceuticals
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, announced the closing of a $20 million equity investment, at $4.03 per share, by Betta Pharmaceuticals (SZ300558) bringing the total received to $35M. Read More »
LANNETT: To Launch Levorphanol Tablets
Signs Exclusive U.S. Distribution Agreement with Novitium Pharma Read More »
MHA: New Long-Term Care Pharmacy Study Highlights Unrecognized Outcomes and Cost Related to Patient Rx Interventions
MHA Study Reveals Member Medication Adherence Rates for Long-Term Care Pharmacies Serving Skilled Nursing and Assisted Living Patients Read More »
Johns Hopkins study shows no drug use relapse from behavioral therapy for PTSD
Johns Hopkins researchers find that standard PTSD treatment does not cause drug use relapse. Read More »
Pharmaceutical companies want intellectual property protections to be key focus
Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research and development (R&D) related to COVID-19, according to PhRMA. Read More »
DELMAR PHARMACEUTICALS: To Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals
Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET Read More »
Pharmaceutical industry works to find COVID-19 vaccine
Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »
NASP: National Association of Specialty Pharmacy Releases Agenda for Fifth Annual Specialty Pharmacy Law Conference
The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »
NEPHRON PHARMACEUTICALS CORPORATION: Announces Historic Expansion in Lexington County
One of the fastest-growing pharmaceuticals companies in the country, headquartered in Lexington County, today announced several major expansion and investment projects. Read More »
Hospital pharmacists more involved in patient care, survey finds
Hospital pharmacists are becoming more involved in patient care and are embracing new technology, a new study found. Read More »
PANTHERX® RARE PHARMACY: Selected by Ultragenyx Pharmaceutical to Distribute DOJOLVI™ (triheptanoin), for Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)
PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVI™ (triheptanoin). DOJOLVI™ (a highly purified, pharmaceutical-grade, synthetic seven carbon fatty acid triglyceride) is a specially designed synthetic triglyceride compound, which was developed to treat patients with long-chain fatty acid oxidation disorders (LC-FAOD). Read More »
ARIDIS PHARMACEUTICALS: To Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald's Virtual Symposium: "Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020. Read More »
APHA: Joint Statement of the American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists on new FDA action to Remove Emergency Use Authorization of Medications to Treat COVID-19
The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists appreciates the Food and Drug Administration's (FDA's) continuing efforts to review and advise the nation on the safe and effective use of hydroxychloroquine, chloroquine, and other medications to prevent and treat coronavirus. Read More »
Alerts Sign-up